Company

Neurocrine Biosciences

Neurocrine Biosciences develops treatments for neurological, neuroendocrine and neuropsychiatric disorders.

About

Founded in 1992 and based in San Diego, Neurocrine Biosciences discovers and develops treatments for neurological, neuroendocrine and neuropsychiatric disorders. Its medicines target conditions including movement and endocrine-related disorders. In May 2026, the company raised USD 600 million in debt funding from JPMorgan Chase.

3Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in